AIDS, vaccino italiano migliora l’effetto farmaci anti-Hiv
All News 24,
Tat, il vaccino sviluppato nei laboratori dell’Istituto Superiore di Sanità dal Centro Nazionale AIDS (CNAIDS) di Roma, diretto…
Tat, il vaccino sviluppato nei laboratori dell’Istituto Superiore di Sanità dal Centro Nazionale AIDS (CNAIDS) di Roma, diretto…
Uno studio dell'ISS condotto in Sudafrica ha confermato l'efficacia di questo vaccino nel migliorare le terapie contro l'HIV/AIDS…
La somministrazione di una piccolissima quantità della proteina Tat induce una risposta immunitaria capace di migliorare l'effica…
Roma - Il vaccino "italiano" Tat sviluppato nei laboratori dell'Istituto Superiore di Sanita' dal Centro Nazionale AIDS (CNAIDS)…
Imagen de archivo de la preparación de una vacuna. (GTRES) La cura ‘funcional’ del VIH podría estar más cerca gracias a una…
ROME, June 8, 2016 /PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat…
/PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AI…
/PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AI…
The CD4 + T cells are pivotal players of the immune response against pathogens but are progressively lost during HIV infection…
/PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AI…
/PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AI…
/PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AI…
Rom (ots/PRNewswire) - Eine in Südafrika durchgeführte, klinische Phase-II-Studie hat bestätigt, dass die therapeutische Tat-Impf…
... ROME June 8 2016 /-...Un essai clinique de phase II réalisé en Afrique du Sud a co...L'essai mené au MeCRU l'Unité de…
/PRNewswire/ -- Eine in Südafrika durchgeführte, klinische Phase-II-Studie hat bestätigt, dass die therapeutische Tat-Impfung…
/PRNewswire/ -- Eine in Südafrika durchgeführte, klinische Phase-II-Studie hat bestätigt, dass die therapeutische Tat-Impfung…
/PRNewswire/ -- Un essai clinique de phase II réalisé en Afrique du Sud a confirmé que le vaccin thérapeutique Tat contre le VIH…
/PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AI…
/PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AI…
/PRNewswire/ -- A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AI…
Un nuovo studio pubblicato su Retrovirology dall'équipe di Barbara Ensoli, direttore del Centro Nazionale Aids dell'Istituto…
A vaccine containing a protein necessary for virus replication can boost an HIV-infected patient’s immune system, according to…
A vaccine containing a protein necessary for virus replication can boost an HIV-infected patient's immune system, according to…
( BioMed Central ) A vaccine containing a protein necessary for virus replication can boost an HIV-infected patient's immune…